| P50 | author | Paul Lichtenstein | Q56460588 |
| | Brian M D'Onofrio | Q56469061 |
| | Arvid Sjölander | Q85617310 |
| | Martin E Rickert | Q91603793 |
| | Henrik Larsson | Q37384205 |
| | Robert D. Gibbons | Q46996511 |
| | Benjamin Bernard Lahey | Q55584563 |
| P2093 | author name string | Patrick D Quinn | |
| | Kwan Hur | |
| | Zheng Chang | |
| P2860 | cites work | ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents | Q22241496 |
| | Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder | Q22242745 |
| | Beyond polemics: science and ethics of ADHD | Q22251019 |
| | Medication for attention deficit-hyperactivity disorder and criminality | Q24619697 |
| | Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents | Q28282770 |
| | Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study | Q33773278 |
| | Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research | Q33900589 |
| | Stimulant ADHD medication and risk for substance abuse | Q34102167 |
| | Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. | Q34169007 |
| | Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study | Q34488557 |
| | Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder | Q57317070 |
| | Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study | Q34667985 |
| | Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents | Q35032482 |
| | Attention-deficit/hyperactivity disorder and risk for drug use disorder: a population-based follow-up and co-relative study | Q35085285 |
| | Annual research review: Optimal outcomes of child and adolescent mental illness | Q36018420 |
| | Predictors of adolescent outcomes among 4-6-year-old children with attention-deficit/hyperactivity disorder | Q36561267 |
| | Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication | Q36659092 |
| | Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD | Q36892982 |
| | Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study | Q37040031 |
| | Representativeness of participants in a clinical trial for attention-deficit/hyperactivity disorder? Comparison with adults from a large observational study | Q37080914 |
| | Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis | Q37404401 |
| | Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study | Q37629463 |
| | Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses | Q37820738 |
| | Stimulant medication and substance use outcomes: a meta-analysis. | Q38113515 |
| | Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence. | Q38241724 |
| | Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents | Q38343322 |
| | Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial | Q38400748 |
| | Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study | Q38415996 |
| | Methylphenidate and the risk of trauma. | Q39209210 |
| | Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents | Q39778992 |
| | Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study | Q39844901 |
| | Childhood attention-deficit/hyperactivity disorder symptoms and the development of adolescent alcohol problems: A prospective, population-based study of Swedish twins | Q40160938 |
| | Negative controls: a tool for detecting confounding and bias in observational studies | Q42587672 |
| | Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design | Q45853628 |
| | Do stimulants prevent substance use and misuse among youth with attention-deficit/hyperactivity disorder? The answer is still maybe | Q46441459 |
| | Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants | Q46485452 |
| | Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder. | Q48027030 |
| | Attention-deficit/hyperactivity disorder and risk for substance use disorders in relatives | Q48162343 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 877-885 | |
| P577 | publication date | 2017-06-29 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | ADHD Medication and Substance-Related Problems | |
| P478 | volume | 174 | |